These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
233 related items for PubMed ID: 1104144
41. Effects of administration to mice of butylated hydroxyanisole by oral intubation on benzo[a]pyrene-induced pulmonary adenoma formation and metabolism of benzo[a]pyrene. Speier JL, Lam LK, Wattenberg LW. J Natl Cancer Inst; 1978 Mar; 60(3):605-9. PubMed ID: 625066 [Abstract] [Full Text] [Related]
42. Benzo(a)pyrene metabolism and metabolites binding to DNA in the presence of BHA. Sawicki J, Selkirk JK, Kugaczewska M, Piekarski L, McLeod MC. Arch Geschwulstforsch; 1980 Mar; 50(4):317-21. PubMed ID: 7458578 [Abstract] [Full Text] [Related]
43. Phenolic antioxidants: Health Protection Branch studies on butylated hydroxyanisole. Iverson F. Cancer Lett; 1995 Jun 29; 93(1):49-54. PubMed ID: 7600543 [Abstract] [Full Text] [Related]
44. Effects of butylated hydroxyanisole on the metabolism of benzo[a]pyrene by mouse liver microsomes. Lam LK, Wattenberg LW. J Natl Cancer Inst; 1977 Feb 29; 58(2):413-7. PubMed ID: 833886 [Abstract] [Full Text] [Related]
51. Microsomal hydroxylases: studies on the mechanism of induction and their role in polycyclic-hydrocarbon action. Gelboin HV. Biochem J; 1971 Nov 29; 125(2):4P-5P. PubMed ID: 5144755 [No Abstract] [Full Text] [Related]
52. The Ah locus and the metabolism of chemical carcinogens and other foreign compounds. Thorgeirsson SS, Nebert DW. Adv Cancer Res; 1977 Nov 29; 25():149-93. PubMed ID: 405846 [No Abstract] [Full Text] [Related]
53. Inhibition of chemical carcinogenesis. Wattenberg LW. J Natl Cancer Inst; 1978 Jan 29; 60(1):11-8. PubMed ID: 342711 [No Abstract] [Full Text] [Related]
54. Effects of co-administration of butylated hydroxytoluene, butylated hydroxyanisole and flavonoids on the activation of mutagens and drug-metabolizing enzymes in mice. Sun B, Fukuhara M. Toxicology; 1997 Sep 26; 122(1-2):61-72. PubMed ID: 9274802 [Abstract] [Full Text] [Related]
55. The relationship between metabolism, DNA binding, and carcinogenicity of 15,16-dihydro-11-methylcyclopenta(alpha)phenanthren-17-one in the presence of a microsomal enzyme inhibitor. Coombs MM, Bhatt TS, Vose CW. Cancer Res; 1975 Feb 26; 35(2):305-9. PubMed ID: 234032 [Abstract] [Full Text] [Related]
56. Protection by indole-3-carbinol against covalent binding of benzo[a]pyrene metabolites to mouse liver DNA and protein. Shertzer HG. Food Chem Toxicol; 1983 Feb 26; 21(1):31-5. PubMed ID: 6298084 [Abstract] [Full Text] [Related]
57. Genetic differences in the metabolism of carcinogens and in the binding of benzo (a) pyrene metabolites to DNA. Boobis AR, Nebert DW. Adv Enzyme Regul; 1976 Feb 26; 15():339-62. PubMed ID: 1030186 [No Abstract] [Full Text] [Related]
58. Inhibition of the mono-oxygenase system by butylated hydroxyanisole and butylated hydroxytoluene. Yang CS, Strickhart FS, Woo GK. Life Sci; 1974 Oct 15; 15(8):1497-505. PubMed ID: 4549991 [No Abstract] [Full Text] [Related]
59. Effect of 2(3)-tert-butyl-4-hydroxyanisole on benzo[a]pyrene metabolism and DNA-binding of benzo[a]pyrene metabolites in isolated mouse hepatocytes. Dock L, Cha YN, Jernström B, Moldéus P. Chem Biol Interact; 1982 Jul 15; 41(1):25-37. PubMed ID: 6284389 [Abstract] [Full Text] [Related]
60. Mode of action of butylated hydroxyanisole (BHA) and other phenols in preventing loss of 11 beta-hydroxylase activity in cultured bovine adrenocortical cells. Hornsby PJ, Aldern KA, Harris SE. Biochem Pharmacol; 1985 Mar 15; 34(6):865-72. PubMed ID: 3872128 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]